Last reviewed · How we verify
Pityriasis versicolor
Approved treatments
- Salonpas
- Lotrimin · Bayer AG
- Exelderm · Journey
- Akrinol
- Mentax · Bayer
- OMOCONAZOLE
Omoconazole works by inhibiting the growth of fungal cells. - Spectazole
Spectazole works by inhibiting the enzyme lanosterol 14α-demethylase, which is necessary for fungal cells to produce ergosterol, a critical component of their cell membranes. - Monistat · Johnson & Johnson (Janssen)
- Nizoral · Johnson & Johnson (Janssen)
- Selsun · Chattem
- Loprox · Bausch Health
- Penlac · 9305-9954 Quebec Inc
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pityriasis versicolor patent landscape — cliff calendar, originator estates, attackable patents
- Pityriasis versicolor treatment landscape brief
- Pityriasis versicolor treatment updates RSS
Frequently asked questions about Pityriasis versicolor
What drugs treat Pityriasis versicolor?
Tracked treatments include Salonpas, Lotrimin, Exelderm, Akrinol, Mentax, OMOCONAZOLE, Spectazole, Monistat.
What is the treatment for Pityriasis versicolor?
Standard treatment for Pityriasis versicolor includes Salonpas, Lotrimin, Exelderm, Akrinol, Mentax. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pityriasis versicolor patent cliff · Pityriasis versicolor CI report
- Treatment: Salonpas
- Treatment: Lotrimin · Bayer AG
- Treatment: Exelderm · Journey
- Treatment: Akrinol
- Treatment: Mentax · Bayer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing